Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Deferred Taxes (2016 - 2018)

China Pharma Holdings filings provide 9 years of Deferred Taxes readings, the most recent being -$1195.0 for Q4 2018.

  • On a quarterly basis, Deferred Taxes fell 103.91% to -$1195.0 in Q4 2018 year-over-year; TTM through Dec 2018 was $68419.0, a 44.21% decrease, with the full-year FY2018 number at $68419.0, down 44.21% from a year prior.
  • Deferred Taxes hit -$1195.0 in Q4 2018 for China Pharma Holdings, down from $21039.0 in the prior quarter.
  • In the past five years, Deferred Taxes ranged from a high of $421825.0 in Q3 2015 to a low of -$1195.0 in Q4 2018.
  • Median Deferred Taxes over the past 5 years was $21039.0 (2018), compared with a mean of $58385.9.
  • Biggest five-year swings in Deferred Taxes: surged 2095.29% in 2015 and later tumbled 103.91% in 2018.
  • China Pharma Holdings' Deferred Taxes stood at $19284.0 in 2014, then surged by 2087.44% to $421825.0 in 2015, then tumbled by 42.36% to $243131.0 in 2016, then plummeted by 87.45% to $30525.0 in 2017, then plummeted by 103.91% to -$1195.0 in 2018.
  • The last three reported values for Deferred Taxes were -$1195.0 (Q4 2018), $21039.0 (Q3 2018), and $22590.0 (Q2 2018) per Business Quant data.